Information Provided By:
Fly News Breaks for December 2, 2019
Dec 2, 2019 | 07:43 EDT
As previously reported, Morgan Stanley analyst Vincent Andrews downgraded Dow Inc. (DOW) to Equal Weight from Overweight with an unchanged price target of $58. Concurrently, Andrews resumed coverage of LyondellBasell (LYB) with an Overweight rating and $110 price target. Though he notes his price target for LyondellBasell, with 19% upside, "is generally not enough for us to advise putting new money to work in a commodity chemical stock," Andrews believes investors should own a commodity name in 2020 and said the polyethylene chain is where he sees the best commodity chemical risk/reward. Consensus expectations for Dow imbed much more improvement in 2020 than they do for LyondellBasell, added Andrews, who also views Lyondell's ability to keep buying back stock and possibly raise its dividend as another key differentiator between the two stocks in 2020.
News For DOW;LYB From the Last 2 Days
Dec 9, 2019 | 11:06 EDT
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA/MERRILL DOUBLE UPGRADES... To see the rest of the story go to See Story Here
Dec 9, 2019 | 10:20 EST
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qorvo (QRVO) and Skyworks (SWKS) double upgraded to Buy from Underperform at BofA/Merrill. 2. Fate Therapeutics (FATE) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jim Birchenough citing this weekend's update for the company's iPSC-derived NK-cell therapeutics pipeline, initial data for iPSC NKcell therapies FT500 and FT516, and updated comments on CD19 CAR-NK therapeutic FT596. 3. Wingstop (WING) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Katherine Fogertey saying while the shares are up over 30% over the past year, they have lagged the S&P 500 by over 30% since August 22 and now trade at a discount to peers. 4. Huntsman (HUN) and Fortive (FTV) upgraded to Buy from Neutral at Citi. 5. Dow Inc. (DOW) and Kraton (KRA) upgraded to Buy from Hold at SunTrust. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.